chr1-209833289-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_014388.7(UTP25):āc.493C>Gā(p.Leu165Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000163 in 1,595,318 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_014388.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UTP25 | NM_014388.7 | c.493C>G | p.Leu165Val | missense_variant | 4/12 | ENST00000491415.7 | NP_055203.4 | |
UTP25 | XM_006711275.4 | c.493C>G | p.Leu165Val | missense_variant | 4/10 | XP_006711338.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UTP25 | ENST00000491415.7 | c.493C>G | p.Leu165Val | missense_variant | 4/12 | 1 | NM_014388.7 | ENSP00000419005.1 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152208Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000215 AC: 5AN: 232156Hom.: 0 AF XY: 0.00000798 AC XY: 1AN XY: 125356
GnomAD4 exome AF: 0.00000554 AC: 8AN: 1443110Hom.: 0 Cov.: 33 AF XY: 0.00000279 AC XY: 2AN XY: 717304
GnomAD4 genome AF: 0.000118 AC: 18AN: 152208Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74348
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2021 | The c.493C>G (p.L165V) alteration is located in exon 4 (coding exon 4) of the DIEXF gene. This alteration results from a C to G substitution at nucleotide position 493, causing the leucine (L) at amino acid position 165 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at